TI - Pathologic Response and Survival After Neoadjuvant Chemotherapy Among Breast Cancer Subtypes: Clinicopathologic and Survival Analysis from Azerbaijan
PT - Journal Article
DP - 2025
TA - EJMI
PG - 161-171
VI - 9
IP - 3
AID - 2025.28172 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2025.28172
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2025 9(3): 161